Release Date: 15/02/13 08:27 Summary: Changes relating to buy-back - Appendix 3D Price Sensitive: Yes Download Document 207.11KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%